These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38395375)

  • 1. The blockade of neuropeptide FF receptor 1 and 2 differentially contributed to the modulating effects on fentanyl-induced analgesia and hyperalgesia in mice.
    Chen D; Zhang M; Zhang Q; Wu S; Yu B; Zhang X; Hu X; Zhang S; Yang Z; Kuang J; Xu B; Fang Q
    Eur J Pharmacol; 2024 Apr; 969():176457. PubMed ID: 38395375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
    Elhabazi K; Humbert JP; Bertin I; Quillet R; Utard V; Schneider S; Schmitt M; Bourguignon JJ; Laboureyras E; Ben Boujema M; Simonnet G; Ancel C; Simonneaux V; Beltramo M; Bucher B; Sorg T; Meziane H; Schneider E; Petit-Demoulière B; Ilien B; Bihel F; Simonin F
    Neuropharmacology; 2017 May; 118():188-198. PubMed ID: 28288815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
    Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPFFR2 Activates the HPA Axis and Induces Anxiogenic Effects in Rodents.
    Lin YT; Yu YL; Hong WC; Yeh TS; Chen TC; Chen JC
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice.
    Lin YT; Liu HL; Day YJ; Chang CC; Hsu PH; Chen JC
    Exp Neurol; 2017 May; 291():62-73. PubMed ID: 28179153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions.
    Malin DH; Henceroth MM; Izygon JJ; Nghiem DM; Moon WD; Anderson AP; Madison CA; Goyarzu P; Ma JN; Burstein ES
    Neurosci Lett; 2015 Jan; 584():141-5. PubMed ID: 25459291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
    Zhang R; Xu B; Zhang Q; Chen D; Zhang M; Zhao G; Xu K; Xiao J; Zhu H; Niu J; Li N; Fang Q
    Eur J Pharmacol; 2020 Aug; 880():173169. PubMed ID: 32416184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
    Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
    Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q; Jiang TN; Li N; Han ZL; Wang R
    Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
    Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
    Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered nociception and morphine tolerance in neuropeptide FF receptor type 2 over-expressing mice.
    Lin YT; Kao SC; Day YJ; Chang CC; Chen JC
    Eur J Pain; 2016 Jul; 20(6):895-906. PubMed ID: 26648516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.
    Nguyen T; Marusich J; Li JX; Zhang Y
    J Med Chem; 2020 Nov; 63(21):12387-12402. PubMed ID: 32673481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
    Zhang T; Han Z; Shi X; Zhao W; Wang Z; Zhang R; Xu B; Zhang M; Zhang Q; Xiao J; Zhu H; Zheng T; Fang Q
    Bioorg Med Chem; 2019 Feb; 27(4):630-643. PubMed ID: 30626554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of G-Protein α-Subunits to Analgesia, Hyperalgesia, and Hyperalgesic Priming Induced by Subanalgesic and Analgesic Doses of Fentanyl and Morphine.
    Araldi D; Bonet IJM; Green PG; Levine JD
    J Neurosci; 2022 Feb; 42(7):1196-1210. PubMed ID: 34965973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
    Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
    Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia.
    Hammoud H; Elhabazi K; Quillet R; Bertin I; Utard V; Laboureyras E; Bourguignon JJ; Bihel F; Simonnet G; Simonin F; Schmitt M
    ACS Chem Neurosci; 2018 Nov; 9(11):2599-2609. PubMed ID: 29727163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesia.
    Bihel F; Humbert JP; Schneider S; Bertin I; Wagner P; Schmitt M; Laboureyras E; Petit-Demoulière B; Schneider E; Mollereau C; Simonnet G; Simonin F; Bourguignon JJ
    ACS Chem Neurosci; 2015 Mar; 6(3):438-45. PubMed ID: 25588572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
    Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
    Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
    Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
    Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an
    Quillet R; Schneider S; Utard V; Drieu la Rochelle A; Elhabazi K; Henningsen JB; Gizzi P; Schmitt M; Kugler V; Simonneaux V; Ilien B; Simonin F; Bihel F
    J Med Chem; 2021 Jun; 64(11):7555-7564. PubMed ID: 34008968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.